Fang-feng Liu
Jinan, 250021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
Journal: World journal of gastroenterology
Published: March 27, 2018
miR-1299 suppresses cell proliferation of hepatocellular carcinoma (HCC) by targeting CDK6.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 30, 2016
Metformin potentiates the anticancer activities of gemcitabine and cisplatin against cholangiocarcinoma cells in vitro and in vivo.
Journal: Oncology reports
Published: May 04, 2016
MiR-1180 promoted the proliferation of hepatocellular carcinoma cells by repressing TNIP2 expression.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: January 28, 2016
Significant Association Between Adiponutrin and Hepatocellular Carcinoma Risk.
Journal: Medicine
Published: December 04, 2015
Aberrant Expression of CCAT1 Regulated by c-Myc Predicts the Prognosis of Hepatocellular Carcinoma.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: July 31, 2015
Association of PTEN gene polymorphisms with liver cancer risk.
Journal: International journal of clinical and experimental pathology
Published: June 23, 2015
PIK3CA polymorphisms associated with susceptibility to hepatocellular carcinoma.
Journal: International journal of clinical and experimental pathology
Published: June 19, 2015
Two polymorphisms of USF1 gene (-202G>A and -844C>T) may be associated with hepatocellular carcinoma susceptibility based on a case-control study in Chinese Han population.
Journal: Medical oncology (Northwood, London, England)
Published: September 11, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026